Matti Kimberg, Principal Scientist

Following his under- and post-graduate education in molecular genetics and biochemistry at the Universities of the Freestate and Stellenbosch respectively, Matti worked for 4 years at the Institute for Infectious Disease and Molecular Medicine (IIDMM) at the University of Cape Town. With the move from molecular biology to immunology, Matti’s research at the IIDMM explored the role of various innate receptors in murine models of cancer immunotherapy and infection. Driven by a passion for applying scientific knowledge to improve medical outcomes, Matti joined Synexa early in early 2011. His role as Lead Scientist includes the development of tailor-made biomarker strategies and assays that are scientifically sound and provide optimal insight into drug safety and efficacy.

Andreia Soares, Principal Scientist

Andreia is a cellular immunologist with extensive experience in advanced immunological techniques, such as multiparameter flow cytometry. She brings with her a unique perspective on biomarker discovery with her background in infectious diseases and clinical immunology. Andreia completed her PhD in Clinical Science and Immunology at the University of Cape Town, which focused on Bacille Calmette Guérin (BCG)-specific T cell mediated immunity following vaccination of newborns. The predominant focus of her post-doctoral work was on new vaccination strategies against HIV. Andreia has several international peer-reviewed publications related to HIV and TB and her area of interest is focused on attaining a better understanding of cellular immunity related to infectious diseases and vaccine induced immune responses. Andreia is based at our London laboratory and leads our work globally in flow cytometry and cell-based assay innovation and application.

Natalie Strickland, Senior Scientist

Natalie completed her undergraduate and postgraduate studies at the University of Stellenbosch in Human Genetics. Her PhD examined the genetic factors regulating iron metabolism using a combination of advanced molecular techniques and bioinformatics. Following her PhD, she completed a five-year postdoctoral research fellowship at the Institute for Infectious Disease and Molecular Medicine (IDM) at the University of Cape Town specializing in infectious disease immunology with a special interest in cellular immunity to HIV/TB co-infection. She has extensive experience in both molecular and advanced immunological techniques, including multiparameter flow cytometry.

Natalie is based in our Cape Town laboratory and oversees work in the development of complex flow cytometry and cell-based assays, translational prototrials and the research and development of new techniques in flow cytometry visualisation, analysis and interpretation.